[The EML4-ALK fusion gene in NSCLC and the clinical progress]
- PMID: 21569650
- PMCID: PMC6000320
- DOI: 10.3779/j.issn.1009-3419.2011.05.10
[The EML4-ALK fusion gene in NSCLC and the clinical progress]
Figures

Similar articles
-
ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.Lung Cancer. 2012 Jan;75(1):66-72. doi: 10.1016/j.lungcan.2011.05.027. Epub 2011 Jul 14. Lung Cancer. 2012. PMID: 21757253 Clinical Trial.
-
Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs.Cell Mol Life Sci. 2016 Mar;73(6):1209-24. doi: 10.1007/s00018-015-2117-6. Epub 2016 Jan 11. Cell Mol Life Sci. 2016. PMID: 26755435 Free PMC article. Review.
-
Echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-targeted therapy for advanced non-small cell lung cancer: molecular and clinical aspects.Cancer Sci. 2012 Aug;103(8):1391-6. doi: 10.1111/j.1349-7006.2012.02327.x. Epub 2012 Jun 17. Cancer Sci. 2012. PMID: 22568572 Free PMC article. Review.
-
Effective enrichment strategy for EML4-ALK fusion gene screening in patients with non-small cell lung cancer.Respir Investig. 2014 Jan;52(1):49-56. doi: 10.1016/j.resinv.2013.06.003. Epub 2013 Aug 1. Respir Investig. 2014. PMID: 24388371
-
New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer.Indian J Cancer. 2017 Jan-Mar;54(1):203-208. doi: 10.4103/ijc.IJC_72_17. Indian J Cancer. 2017. PMID: 29199691
References
-
- Shiota M, Fujimoto J, Semba T, et al. Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. http://www.nature.com/articles/1210346. Oncogene. 1994;9(6):1567–1574. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical